English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 955114 線上人數 : 587
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
搜尋範圍
全部NHRI
癌症研究所
陳立宗
--期刊論文
--圖書
--會議論文/會議摘要
查詢小技巧:
您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
進階搜尋
主頁
‧
登入
‧
上傳
‧
說明
‧
關於NHRI
‧
管理
國家衛生研究院 NHRI
>
癌症研究所
>
陳立宗
>
依題名瀏覽
依作者瀏覽
依日期瀏覽
依資料類型瀏覽
社群詳細資訊
簡介:
NA
資料載入中.....
子類別
期刊論文
[
328
/331]
圖書
[
1
/1]
會議論文/會議摘要
[
115
/179]
鄰近社群
于重元
[
19
/19]
劉柯俊
[
85
/98]
劉滄梧
[
119
/125]
劉界元(2003-2010)
[
3
/3]
夏和雄(1996-2012)
[
26
/31]
夏興國
[
51
/54]
姜乃榕
[
82
/94]
常慧如
[
39
/44]
張俊彥
[
234
/254]
張光裕
[
69
/79]
張憶壽
[
104
/107]
張文祥
[
52
/53]
張書銘
[
89
/91]
彭汪嘉康(1996-2007)
[
120
/126]
施能耀
[
37
/43]
李家惠
[
29
/29]
李岳倫
[
48
/49]
林素芳
[
32
/32]
楊奕馨
[
41
/42]
江士昇
[
88
/90]
沈哲宏
[
14
/16]
洪文俊
[
88
/88]
莊雙恩
[
82
/91]
蔡坤志
[
32
/34]
蔡慧珍
[
67
/72]
蘇勇曄
[
40
/40]
蘇振良
[
24
/25]
郭靜娟
[
71
/76]
陳尚鴻
[
45
/48]
陳振陽
[
72
/72]
陳美霞(2002-2009)
[
1
/1]
陳詩政
[
2
/2]
陳雅雯
[
38
/39]
黃智興
[
55
/55]
黃道揚
[
26
/26]
丁兆治(2000-2004)
[
5
/5]
其他
[
465
/472]
劉敏(1996-2007)
[
60
/62]
劉玫英(2004-2006)
[
2
/2]
吳成文(1996-2008)
[
53
/55]
曾思文(1997-2007)
[
4
/4]
李冠德(1997-2004)
[
4
/6]
林景太(1999-2007)
[
5
/5]
楊文光(1996-1999)
[
21
/21]
王全正(1996-2003)
[
4
/4]
莊聲宏(1997-2004)
[
11
/11]
詹宗晃(2000-2008)
[
2
/2]
賴基銘(2004-2008)
[
41
/47]
阮麗蓉(2000-2006)
[
6
/7]
陳俊叡(2003-2007)
[
6
/6]
馬彥英(1997-1999)
[
1
/1]
黃奇英(2005-2007)
[
9
/10]
社群統計
近3年內發表的文件:75(14.68%)
含全文筆數:444(86.89%)
文件下載次數統計
下載大於0次:444(100.00%)
下載大於100次:426(95.95%)
檔案下載總次數:178521(3.33%)
最後更新時間: 2024-12-03 09:06
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
Cooperative participation of CagA a...
Pan-Asian adapted ESMO clinical pra...
Nivolumab plus chemotherapy in pati...
Survival of advanced/recurrent gast...
Topiramate suppresses peri-infarct ...
A phase 1 study of biweekly nab-pac...
Plain language summary of the FOENI...
Outcomes of post-immunotherapy dura...
Durvalumab or placebo plus gemcitab...
Impact of previous S-1 treatment on...
跳至:
(選擇年份)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目76-100 / 511. (共21頁)
<<
<
1
2
3
4
5
6
7
8
9
10
>
>>
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2021-11-30
Survival outcomes of management in metastatic gastric adenocarcinoma patients
Scientific Reports. 2021 Nov 30;11:Article number 23142.
2021-11-20
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
Therapeutic Advances in Medical Oncology. 2021 Nov 20;Article in Press.
2021-11-12
The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience
Frontiers in Oncology. 2021 Nov 12;11:Article number 741096.
2021-10-30
Assessment of brain functional activity using a miniaturized head-mounted scanning photoacoustic imaging system in awake and freely moving rats
Biosensors. 2021 Oct 30;11(11):Article number 429.
2021-10
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: A randomised, double-blind, multicentre, phase 2 study
Lancet Oncology. 2021 Oct;22(10):1468-1482.
2021-09-10
Stromal galectin-1 promotes colorectal cancer cancer-initiating cell features and disease dissemination through SOX9 and Beta-catenin: Development of niche-based biomarkers
Frontiers in Oncology. 2021 Sep 10;11:Article number 716055.
2021-09
A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer
Annals of Oncology. 2021 Sep;32(Suppl. 5):S377.
2021-09
INTEGRATE IIb: A randomised phase III open label study of regorafenib plus nivolumab vs standard chemotherapy in refractory advanced gastro-oesophageal cancer (AGOC)
Annals of Oncology. 2021 Sep;32(Suppl. 5):S1074.
2021-09
Primary results of phase 2 FOENIX-CCA2: the irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
Oncology Research and Treatment. 2021 Sep;44(Suppl. 2):222.
2021-08-03
An adjustable dark-field acoustic-resolution photoacoustic imaging system with fiber bundle-based illumination
Biosensors-Basel. 2021 Aug 3;11(8):Article number 262.
2021-07-26
Cancer registry coding via hybrid neural symbolic systems in the cross-hospital setting
IEEE Access. 2021 Jul 26;9:112081-112096.
2021-07-23
AUY922 induces retinal toxicity through attenuating TRPM1
Journal of Biomedical Science. 2021 Jul 23;28:Article number 55.
2021-07-15
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol
Scientific Reports. 2021 Jul 15;11:Article number 14567.
2021-07-15
How may ramucirumab help improve treatment outcome for patients with gastrointestinal cancers?
Cancers. 2021 Jul 15;13(14):Article number 3536.
2021-07
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
Gastric Cancer. 2021 Jul;24(4):946-958.
2021-07
Primary results of phase 2 FOENIX-CCA2: The irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
Cancer Research. 2021 Jul;81(13, Suppl.):Abstract number CT010.
2021-06-22
A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.]
Frontiers in Oncology. 2021 Jun 22;11:Article number 718849.
2021-06-12
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.
2021-06-07
In vivo assessment of hypoxia levels in pancreatic tumors using a dual-modality ultrasound/photoacoustic imaging system
Micromachines. 2021 Jun 7;12(6):Article number 668.
2021-05-31
A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells
Frontiers in Oncology. 2021 May 31;11:Article number 638311.
2021-05
High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
Radiotherapy and Oncology. 2021 May;158:146-154.
2021-05
Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)
Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 4090.
2021-05
TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma
Journal of Clinical Oncology. 2021 May;39(15, Suppl.):4143.
2021-05
A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy
Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
2021-04-28
Inhibition of Beta-catenin activity abolishes LKB1 loss-driven pancreatic cystadenoma in mice
International Journal of Molecular Sciences. 2021 Apr 28;22(9):Article number 4649.
顯示項目76-100 / 511. (共21頁)
<<
<
1
2
3
4
5
6
7
8
9
10
>
>>
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋